{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:48:29Z","timestamp":1793792909057,"version":"4.6.1"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108255","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:26:48Z","timestamp":1634340408000},"page":"108255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"PB","title":["The triumvirate of NF-\u03baB, inflammation and cytokine storm in COVID-19"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-0255","authenticated-orcid":false,"given":"Ali","family":"Attiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lui Jin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryar","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.intimp.2021.108255_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"issue":"15","key":"10.1016\/j.intimp.2021.108255_b0010","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.3390\/ijms21155475","article-title":"SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms","volume":"21","author":"Pennisi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet. Resp. Medi."},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0020","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/jmv.25944","article-title":"Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection","volume":"92","author":"Xu","year":"2020","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108255_b0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2021.108255_b0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2021.108255_b0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-50998-8_9","article-title":"The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation","author":"Chatenoud","year":"1991","journal-title":"Superantigens"},{"key":"10.1016\/j.intimp.2021.108255_b0040","first-page":"1216","article-title":"Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1","author":"Ferrara","year":"1993","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.15644","article-title":"Cytokine release syndrome and neurotoxicity after CD 19 chimeric antigen receptor-modified (CAR-) T cell therapy","volume":"183","author":"Hay","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17474086.2019.1585238","article-title":"Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy","volume":"12","author":"Acharya","year":"2019","journal-title":"Expert Rev. Hematol."},{"issue":"100","key":"10.1016\/j.intimp.2021.108255_b0060","first-page":"265","article-title":"Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer","volume":"18","author":"Magee","year":"2014","journal-title":"Discov. Med."},{"issue":"23","key":"10.1016\/j.intimp.2021.108255_b0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"NEJM."},{"key":"10.1016\/j.intimp.2021.108255_b0070","article-title":"Agents to reduce cytokine storm, F1000","volume":"5","author":"Gerlach","year":"2016","journal-title":"Research"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.icb.7100062","article-title":"The advent of the cytokine storm","volume":"85","author":"Clark","year":"2007","journal-title":"Immun. Cell. Biol."},{"issue":"7111","key":"10.1016\/j.intimp.2021.108255_b0080","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature05181","article-title":"Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus","volume":"443","author":"Kash","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0085","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Inves."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.cdd.4401870","article-title":"Dissection of the NF-\u03baB signalling cascade in transgenic and knockout mice","volume":"13","author":"Pasparakis","year":"2006","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00204-015-1470-4","article-title":"NF-\u03baB in cancer therapy","volume":"89","author":"Li","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.intimp.2021.108255_b0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Cross-talk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"issue":"976","key":"10.1016\/j.intimp.2021.108255_b0105","article-title":"Raging the War Against Inflammation With Natural Products","volume":"9","author":"Attiq","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00210-020-02035-5","article-title":"NF-\u03baB signalling as a pharmacological target in COVID-19: potential roles for IKK\u03b2 inhibitors","volume":"394","author":"Kandasamy","year":"2021","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1745-7270.2005.00082.x","article-title":"Activation of NF-\u03baB by the full-length nucleocapsid protein of the SARS coronavirus","volume":"37","author":"Liao","year":"2005","journal-title":"Acta. Biochimica et Biophysica Sinica"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"NF-\u03baB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2021.108255_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109766","article-title":"Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-\u03baB1\/p105 to NF-\u03baB\/p50","volume":"75","author":"Jamal","year":"2020","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0140","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.intimp.2021.108255_b0145","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1074\/jbc.M112475200","article-title":"Signaling molecules of the NF-\u03baB pathway shuttle constitutively between cytoplasm and nucleus","volume":"277","author":"Birbach","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00109-019-01777-x","article-title":"Activation of NF-\u03baB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of I\u03baB-\u03b1","volume":"97","author":"Pontoriero","year":"2019","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/ijms18010205","article-title":"Post-translational modifications of the TAK1-TAB complex","volume":"18","author":"Hirata","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0160","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1111\/jcmm.14330","article-title":"The role of post-translational modifications in cardiac hypertrophy","volume":"23","author":"Yan","year":"2019","journal-title":"J. Cell. Mole. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The non-canonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2021.108255_b0175","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00018-008-8064-8","article-title":"TLR-4, IL-1R and TNF-R signaling to NF-\u03baB: variations on a common theme","volume":"65","author":"Verstrepen","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bst0280563","article-title":"Toll-like receptor family and signalling pathway","volume":"28","author":"Muzio","year":"2000","journal-title":"Biochem. Soc. Trans."},{"issue":"18","key":"10.1016\/j.intimp.2021.108255_b0185","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"issue":"11","key":"10.1016\/j.intimp.2021.108255_b0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2021.108255_b0195","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","article-title":"NF-\u03baB signaling in macrophages: dynamics, crosstalk, and signal integration","volume":"10","author":"Dorrington","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","article-title":"The lymphotoxin-\u03b2 receptor induces different patterns of gene expression via two NF-\u03baB pathways","volume":"17","author":"Dejardin","year":"2002","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0205","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.celrep.2013.10.022","article-title":"Context-specific BAFF-R signaling by the NF-\u03baB and PI3K pathways","volume":"5","author":"Jellusova","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2021.108255_b0210","doi-asserted-by":"crossref","unstructured":"W. Zhang, Q. Shi, X. Xu, H. Chen, W. Lin, F. Zhang, X. Zeng, X. Zhang, D. Ba, W. He, Aberrant CD40-induced NF-\u03baB activation in human lupus B lymphocytes, 2012.","DOI":"10.1371\/journal.pone.0041644"},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0215","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.170.6.3099","article-title":"CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-\u03baB, AP-1, and C\/EBP","volume":"170","author":"Baccam","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0220","first-page":"6605","article-title":"TNF-\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF-\u03baB pathway","volume":"17","author":"Luo","year":"2018","journal-title":"Mol. Med. Report."},{"key":"10.1016\/j.intimp.2021.108255_b0225","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fphar.2017.00752","article-title":"Annonaceae: breaking the wall of inflammation","volume":"8","author":"Attiq","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108255_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114120","article-title":"Luteolin and apigenin derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma","volume":"275","author":"Attiq","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","article-title":"I\u03baB kinases: key regulators of the NF-\u03baB pathway","volume":"29","author":"Yamamoto","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2021.108255_b0240","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fphar.2018.00976","article-title":"Raging the war against inflammation with natural products","volume":"9","author":"Attiq","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108255_b0245","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-021-00807-w","article-title":"A new prenylated benzoquinone from Cyathocalyx pruniferus abrogates LPS-induced inflammatory responses associated with PGE2, COX-2 and cytokines biosynthesis in human plasma","author":"Attiq","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"49","key":"10.1016\/j.intimp.2021.108255_b0250","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1038\/sj.onc.1203236","article-title":"Genetic approaches in mice to understand Rel\/NF-\u03baB and I\u03baB function: transgenics and knockouts","volume":"18","author":"Gerondakis","year":"1999","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0255","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-\u03baB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"issue":"51","key":"10.1016\/j.intimp.2021.108255_b0260","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1038\/sj.onc.1209939","article-title":"Mutations in the NF-\u03ba B signaling pathway: implications for human disease","volume":"25","author":"Courtois","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-\u03baB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2021.108255_b0280","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/jmcb\/mjaa071","article-title":"SARS-CoV-2 infection and the antiviral innate immune response","volume":"12","author":"Yang","year":"2020","journal-title":"J. Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2021.108255_b0285","first-page":"1","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","author":"V\u2019kovski","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"7819","key":"10.1016\/j.intimp.2021.108255_b0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.108255_b0295","article-title":"SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done, Wiley Online","author":"Luo","year":"2021","journal-title":"Library"},{"issue":"7","key":"10.1016\/j.intimp.2021.108255_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006422","article-title":"Activation of NF-kB pathway by virus infection requires Rb expression","volume":"4","author":"Garcia","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.intimp.2021.108255_b0305","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.4049\/jimmunol.168.12.6429","article-title":"Protein kinase R regulates double-stranded RNA induction of TNF-\u03b1 but not IL-1\u03b2 mRNA in human epithelial cells","volume":"168","author":"Meusel","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108255_b0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.redox.2017.08.011","article-title":"PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes","volume":"14","author":"Ma","year":"2018","journal-title":"Redox biology"},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0315","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-\u03baB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2021.108255_b0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0325","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2012.03.012","article-title":"NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of non-canonical NF-\u03baB signaling","volume":"36","author":"Allen","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.108255_b0330","first-page":"1","article-title":"The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients","author":"Hariharan","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0335","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.1206763","article-title":"Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation","volume":"82","author":"Hu","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"41","key":"10.1016\/j.intimp.2021.108255_b0340","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1038\/onc.2012.517","article-title":"Non-canonical Notch signaling activates IL-6\/JAK\/STAT signaling in breast tumor cells and is controlled by p53 and IKK\u03b1\/IKK\u03b2","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0345","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000079706","article-title":"Role of JAK\/STAT pathway in IL-6-induced activation of vascular smooth muscle cells","volume":"24","author":"Watanabe","year":"2004","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0350","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT 3 promotes IFN \u03b3\/TNF \u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2021.108255_b0355","article-title":"IL-6 in inflammation, autoimmunity and cancer","author":"Hirano","year":"2020","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0360","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.celrep.2013.01.028","article-title":"Disease-association analysis of an inflammation-related feedback loop","volume":"3","author":"Murakami","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-13-2322","article-title":"Inflammation amplifier, a new paradigm in cancer biology","volume":"74","author":"Atsumi","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0370","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.25763","article-title":"IL-6-STAT3 signaling and premature senescence","volume":"2","author":"Kojima","year":"2013","journal-title":"Jak-stat"},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02942-2","article-title":"Age and sex differences in soluble ACE2 may give insights for COVID-19","volume":"24","author":"Sw\u00e4rd","year":"2020","journal-title":"Critical Care"},{"key":"10.1016\/j.intimp.2021.108255_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102801","article-title":"COVID-19 as a STING disorder with delayed over-secretion of interferon-beta","volume":"56","author":"Berthelot","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2021.108255_b0385","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2016.12.028","article-title":"Rationale for stimulator of interferon genes\u2013targeted cancer immunotherapy","volume":"75","author":"Vargas","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2021.108255_b0390","first-page":"1139","article-title":"Discovery and mechanistic study of a novel human-stimulator-of-interferon-genes agonist, ACS","volume":"5","author":"Zhang","year":"2019","journal-title":"Infect. Diseas."},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0395","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.4049\/jimmunol.1700699","article-title":"NEMO\u2013IKK\u03b2 are essential for IRF3 and NF-\u03baB activation in the cGAS\u2013STING pathway","volume":"199","author":"Fang","year":"2017","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0400","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/JVI.00037-14","article-title":"Cytosolic-DNA-mediated, STING-dependent pro-inflammatory gene induction necessitates canonical NF-\u03baB activation through TBK1","volume":"88","author":"Abe","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni748","article-title":"p38-dependent marking of inflammatory genes for increased NF-\u03baB recruitment","volume":"3","author":"Saccani","year":"2002","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0410","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jcb.21717","article-title":"p38\/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes","volume":"104","author":"Ulivi","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK\u2013RAS\u2013RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0420","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/physrev.00028.2011","article-title":"Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update","volume":"92","author":"Kyriakis","year":"2012","journal-title":"Physiol. Rev."},{"issue":"26","key":"10.1016\/j.intimp.2021.108255_b0425","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.7150\/thno.50992","article-title":"Virus-induced p38 MAPK activation facilitates viral infection","volume":"10","author":"Cheng","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-1702(02)00356-8","article-title":"Hepatitis viruses and the MAPK pathway: is this a survival strategy?","volume":"92","author":"Panteva","year":"2003","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0435","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000256831.33459.ea","article-title":"p38 Mitogen-activated protein kinase inhibition ameliorates angiotensin II\u2013Induced Target Organ Damage","volume":"49","author":"Park","year":"2007","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0440","doi-asserted-by":"crossref","first-page":"C1229","DOI":"10.1152\/ajpcell.00620.2004","article-title":"Differential effects of NF-\u03baB and p38 MAPK inhibitors and combinations thereof on TNF-\u03b1-and IL-1\u03b2-induced pro-inflammatory status of endothelial cells in vitro","volume":"289","author":"Ku\u0142do","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"16","key":"10.1016\/j.intimp.2021.108255_b0445","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1042\/CS20200904","article-title":"Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission","volume":"134","author":"Battagello","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.intimp.2021.108255_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","author":"Devaux","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.intimp.2021.108255_b0455","article-title":"Cytokine storm syndrome in coronavirus disease 2019: A narrative review","author":"Gao","year":"2020","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0460","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet. Infect. Dise."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0465","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.108255_b0470","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fimmu.2021.666223","article-title":"Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis","volume":"12","author":"Zawawi","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0475","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury","volume":"7","author":"Liu","year":"2020","journal-title":"Nat. Sci. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2021.108255_b0480","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0485","first-page":"9","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","volume":"34","author":"Kritas","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"6508","key":"10.1016\/j.intimp.2021.108255_b0490","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.108255_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-\u03b1 induced by SARS-coronavirus spike protein in murine macrophages via NF-\u03baB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0505","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.stem.2020.09.013","article-title":"SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response","volume":"27","author":"Huang","year":"2020","journal-title":"Cell. Stem. Cell"},{"key":"10.1016\/j.intimp.2021.108255_b0510","doi-asserted-by":"crossref","unstructured":"M.R. Islam, A. Fischer, A Transcriptome analysis identifies potential preventive and therapeutic approaches towards COVID-19, 2020.","DOI":"10.20944\/preprints202004.0399.v1"},{"key":"10.1016\/j.intimp.2021.108255_b0515","article-title":"Review 2:\u201c SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro\u201d","author":"H\u00f6lscher","year":"2020","journal-title":"Rapid. Rev. COVID-19"},{"key":"10.1016\/j.intimp.2021.108255_b0520","article-title":"SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro","author":"Hsu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.intimp.2021.108255_b0525","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598444","article-title":"NF-\u03baB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients","volume":"11","author":"Kircheis","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0530","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/ijms20020409","article-title":"Endoplasmic reticulum (ER) stress and unfolded protein response (UPR) in mammalian oocyte maturation and preimplantation embryo development","volume":"20","author":"Lin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.intimp.2021.108255_b0535","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0540","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0545","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"16","key":"10.1016\/j.intimp.2021.108255_b0555","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"NEJM."},{"key":"10.1016\/j.intimp.2021.108255_b0560","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108255_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"Cytokine storm in COVID-19 and treatment","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2021.108255_b0570","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia","volume":"53","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0575","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of Takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"NEJM."},{"issue":"7","key":"10.1016\/j.intimp.2021.108255_b0580","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011222","article-title":"COVID-19\u2013associated stress (Takotsubo) cardiomyopathy","volume":"13","author":"Tsao","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0585","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00002371-200107000-00004","article-title":"Guidelines for the safe administration of high-dose interleukin-2","volume":"24","author":"Schwartzentruber","year":"2001","journal-title":"J. Immunother."},{"issue":"S1","key":"10.1016\/j.intimp.2021.108255_b0590","article-title":"C-reactive protein: An inflammatory marker with specific role in physiology, pathology, and diagnosis","volume":"2","author":"Chandrashekara","year":"2014","journal-title":"Int. J. Rheum. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108255_b0595","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00264-017-3430-5","article-title":"C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infections","volume":"41","author":"P\u00e9rez-Prieto","year":"2017","journal-title":"Int. Orthop."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0600","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.108255_b0605","article-title":"The looming storm: blood and cytokines in COVID-19","volume":"100743","author":"Kaur","year":"2020","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0610","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201ccytokine storm\u201d relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA. Int. Med."},{"issue":"6490","key":"10.1016\/j.intimp.2021.108255_b0615","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2021.108255_b0620","article-title":"Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report","author":"R.C. Group","year":"2020","journal-title":"NEJM"},{"issue":"7821","key":"10.1016\/j.intimp.2021.108255_b0625","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"6515","key":"10.1016\/j.intimp.2021.108255_b0630","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"6515","key":"10.1016\/j.intimp.2021.108255_b0635","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0640","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2021.108255_b0645","first-page":"247","article-title":"Prevalence of comorbidities in COVID-19 patients: A systematic review and meta-analysis","volume":"8","author":"Baradaran","year":"2020","journal-title":"Arch. Bone Joint Surg."},{"key":"10.1016\/j.intimp.2021.108255_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: Deleterious impact on infected patients","author":"Ejaz","year":"2020","journal-title":"J. Infec. Pub. Heal."},{"key":"10.1016\/j.intimp.2021.108255_b0655","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease, 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0660","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0665","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Caricchio","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0670","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/cbin.11403","article-title":"Lymphopenia in COVID-19: Therapeutic opportunities","volume":"44","author":"Fathi","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0675","first-page":"1","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2021.108255_b0680","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2021.108255_b0685","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2021.108255_b0690","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2021.108255_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0700","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2021.108255_b0705","unstructured":"N.C. Institute, 2009. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"10.1016\/j.intimp.2021.108255_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0715","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.2000513","article-title":"Inflammasomes and pyroptosis as therapeutic targets for COVID-19","volume":"205","author":"Yap","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108255_b0720","unstructured":"N. Duran, W.J. Favaro, Pyroptosis: Physiological roles in viral infection, arXiv preprint arXiv:2006.15777, 2020."},{"key":"10.1016\/j.intimp.2021.108255_b0725","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0730","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0735","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.cdd.4402194","article-title":"The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation","volume":"14","author":"Fernandes-Alnemri","year":"2007","journal-title":"Cell. Death. Differ."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0740","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0745","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0750","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Key role of DAMP in inflammation, cancer, and tissue repair","volume":"38","author":"Pandolfi","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.intimp.2021.108255_b0755","doi-asserted-by":"crossref","unstructured":"M. Yang, Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection, Available at SSRN 3527420, 2020.","DOI":"10.2139\/ssrn.3527420"},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b0760","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0765","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MLR.0000000000001337","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Inten","volume":"46","author":"Zhang","year":"2020","journal-title":"Care. Med."},{"issue":"22","key":"10.1016\/j.intimp.2021.108255_b0770","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2021.108255_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.09.013","article-title":"Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms","author":"Sanghai","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0780","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arr.2007.09.002","article-title":"Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging","volume":"7","author":"Salminen","year":"2008","journal-title":"Ageing. Res. Rev."},{"key":"10.1016\/j.intimp.2021.108255_b0785","doi-asserted-by":"crossref","unstructured":"R.A. Al-Lami, R.J. Urban, E. Volpi, A.M. Algburi, J. Baillargeon, Sex hormones and novel corona virus infectious disease (COVID-19), Mayo Clin. Proc., Elsevier, 2020.","DOI":"10.1016\/j.mayocp.2020.05.013"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0790","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/20009666.2020.1781030","article-title":"COVID-19 infection and its deadly cytokine storm in a young obese adult","volume":"10","author":"Abbas","year":"2020","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.intimp.2021.108255_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","volume":"215","author":"Sawalha","year":"2020","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0800","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/S1049023X20000837","article-title":"An insight into the sex differences in COVID-19 patients: what are the possible causes?","volume":"35","author":"Dana","year":"2020","journal-title":"Prehosp. Disaster Med."},{"key":"10.1016\/j.intimp.2021.108255_b0805","series-title":"Are sex discordant outcomes in COVID-19 related to sex hormones?","author":"Strope","year":"2020"},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0810","first-page":"1","article-title":"Molecular mechanisms of sex bias differences in COVID-19 mortality","volume":"24","author":"Li","year":"2020","journal-title":"Criti. Care"},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0815","first-page":"339","article-title":"Coronavirus COV-19\/SARS-CoV-2 affects women less than men: clinical response to viral infection","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.intimp.2021.108255_b0820","article-title":"Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome","volume":"1\u20136","author":"Foresta","year":"2020","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0825","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1720387","article-title":"Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women","volume":"172","author":"Rachon","year":"2002","journal-title":"J. Endocrinol."},{"issue":"23","key":"10.1016\/j.intimp.2021.108255_b0830","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.intimp.2021.108255_b0840","article-title":"COVID-19 cytokines and the hyperactive immune response: Synergism of TNF-\u03b1 and IFN-\u03b3 in triggering inflammation, tissue damage, and death","author":"Karki","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.intimp.2021.108255_b0845","first-page":"1","article-title":"NF-\u03baB signalling as a pharmacological target in COVID-19: potential roles for IKK\u03b2 inhibitors","author":"Kandasamy","year":"2021","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0850","first-page":"258","article-title":"Statin therapy in COVID-19 infection","volume":"6","author":"Castiglione","year":"2020","journal-title":"EHJ-CVP."},{"issue":"48","key":"10.1016\/j.intimp.2021.108255_b0855","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0860","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.intimp.2021.108255_b0865","first-page":"A21","article-title":"Antiviral Activity of the Proteasome Inhibitor VL-01 against Human and Avian Influenza A Viruses","volume":"90","author":"Hamasaki","year":"2011","journal-title":"Abstracts\/Antiviral Research"},{"key":"10.1016\/j.intimp.2021.108255_b0870","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 preliminary report, The","author":"Beigel","year":"2020","journal-title":"NEJM"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2021.108255_b0875","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","article-title":"N-Acetylcysteine suppresses TNF-induced NF-\u03baB activation through inhibition of I\u03baB kinases","volume":"472","author":"Oka","year":"2000","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0880","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3892\/mmr.2014.2292","article-title":"N-acetylcysteine reduces oxidative stress, nuclear factor-\u03baB activity and cardiomyocyte apoptosis in heart failure","volume":"10","author":"Wu","year":"2014","journal-title":"Mol. Med. Report."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0885","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0899-9007(96)00000-8","article-title":"Inflammation, free radicals, and antioxidants","volume":"12","author":"Conner","year":"1996","journal-title":"Nutrition"},{"issue":"45","key":"10.1016\/j.intimp.2021.108255_b0890","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013087","article-title":"N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b0895","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","volume":"82","author":"Mata","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108255_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109778","article-title":"N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome","volume":"140","author":"Assimakopoulos","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.intimp.2021.108255_b0905","unstructured":"ClinicalTrials.gov.2020, Efficacy of n-acetylcysteine (NAC) in preventing COVID-19 from progressing to severe disease. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04419025 (accessed 11 Aug 2020)."},{"issue":"10234","key":"10.1016\/j.intimp.2021.108255_b0910","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.intimp.2021.108255_b0915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2020.03.013","article-title":"Old and new antirheumatic drugs for the treatment of COVID-19","volume":"87","author":"Benucci","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2021.108255_b0920","unstructured":"SECURE-IBD.database.2020, surveillance epidemiology of coronavirus (COVID-19) under research exclusion. https:\/\/covidibd.org\/current-data\/ (accessed 11 Aug 2020)."},{"issue":"13","key":"10.1016\/j.intimp.2021.108255_b0925","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.intimp.2021.108255_b0930","doi-asserted-by":"crossref","first-page":"489","DOI":"10.12788\/jhm.3497","article-title":"Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19","volume":"15","author":"Keller","year":"2020","journal-title":"J. Hosp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0935","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000091126","article-title":"Nuclear Factor-\u0138B-and Glucocorticoid Receptor \u03b1-Mediated Mechanisms in the Regulation of Systemic and Pulmonary Inflammation during Sepsis and Acute Respiratory Distress Syndrome","volume":"12","author":"Meduri","year":"2005","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1016\/j.intimp.2021.108255_b0940","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1203\/01.pdr.0000219120.92049.b3","article-title":"Dexamethasone suppresses expression of Nuclear Factor-kappaB in the cells of tracheobronchial lavage fluid in premature neonates with respiratory distress","volume":"59","author":"Aghai","year":"2006","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b0945","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.intimp.2021.108255_b0950","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.4049\/jimmunol.1700352","article-title":"Cutting edge: distinct regulatory mechanisms control pro-inflammatory cytokines IL-18 and IL-1\u03b2","volume":"198","author":"Zhu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108255_b0955","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"1057","key":"10.1016\/j.intimp.2021.108255_b0960","article-title":"The Role of Interleukin 6 During Viral Infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2021.108255_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155323","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2021","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.intimp.2021.108255_b0970","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0975","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Wojno","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2021.108255_b0980","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications","volume":"10","author":"Monin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2021.108255_b0985","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique action of interleukin-18 on T cells and other immune cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108255_b0990","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2021.108255_b0995","article-title":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches","volume":"1\u20138","author":"Lang","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108255_b1000","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1074\/mcp.M116.064428","article-title":"Vascular endothelial growth factor (VEGF) promotes assembly of the p130Cas interactome to drive endothelial chemotactic signaling and angiogenesis","volume":"16","author":"Evans","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"44","key":"10.1016\/j.intimp.2021.108255_b1005","doi-asserted-by":"crossref","first-page":"77020","DOI":"10.18632\/oncotarget.20331","article-title":"VEGF stimulated the angiogenesis by promoting the mitochondrial functions","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.intimp.2021.108255_b1010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tube.2003.09.003","article-title":"Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis","volume":"84","author":"Lyons","year":"2004","journal-title":"Tuberculosis"},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b1015","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1080\/21645515.2019.1696075","article-title":"Significance of the IL-8 pathway for immunotherapy","volume":"16","author":"Gonzalez-Aparicio","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2021.108255_b1020","article-title":"Relationship of IP-10 gene expression to systemic lupus erythematosus activity","author":"Torres-V\u00e1zquez","year":"2021","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"10.1016\/j.intimp.2021.108255_b1025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fped.2019.00244","article-title":"Aetiological significance of infectious stimuli in Kawasaki disease","volume":"7","author":"Nakamura","year":"2019","journal-title":"Front. Ped."},{"key":"10.1016\/j.intimp.2021.108255_b1030","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.30375","article-title":"The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases","author":"Zhu","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2021.108255_b1035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-30273-7_2","article-title":"Role of cytokines","volume":"Springer","author":"Khan","year":"2016","journal-title":"Immunopharmacology"},{"issue":"10","key":"10.1016\/j.intimp.2021.108255_b1040","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","article-title":"Macrophage inflammatory protein-1","volume":"36","author":"Maurer","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2021.108255_b1045","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.38173","article-title":"A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium","volume":"65","author":"Kobayashi","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.108255_b1050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2021.108255_b1055","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012642","article-title":"Rationale for targeting complement in COVID-19","volume":"12","author":"Polycarpou","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"15","key":"10.1016\/j.intimp.2021.108255_b1060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140711","article-title":"The complement system in COVID-19: friend and foe?","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2021.108255_b1065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijid.2020.05.110","article-title":"Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?","volume":"97","author":"Edeas","year":"2020","journal-title":"Int. J. Infect. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:38:34Z","timestamp":1761586714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":213,"alternative-id":["S1567576921008912"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108255","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The triumvirate of NF-\u03baB, inflammation and cytokine storm in COVID-19","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108255"}}